CHD1 Protein

CHD1 Protein

Overview

CHD1 (Chromodomain Helicase DNA Binding Protein 1) is an ATP-dependent chromatin remodeler essential for regulating gene expression, maintaining genomic integrity, and orchestrating epigenetic programs in eukaryotes. As a member of the SNF2H family of chromatin remodelers, CHD1 uses the energy from ATP hydrolysis to slide, restructure, and evict nucleosomes, thereby facilitating transcription factor access to DNA and maintaining proper chromatin architecture. With a molecular weight of ~223 kDa and containing 2,074 amino acids, CHD1 is particularly critical in neurons where precise epigenetic regulation underlies synaptic plasticity, learning, memory, and neuronal survival[@kelley2019].

CHD1 is distinguished by its two N-terminal chromodomains that specifically recognize methylated histone H3K4me3, targeting the protein to active promoter regions. The protein also contains SANT domains for histone tail binding and a central ATPase domain that performs nucleosome remodeling. CHD1 is essential for embryonic development, stem cell pluripotency, and neuronal function, making it a critical protein in both development and disease contexts.

<div class="infobox infobox-protein">

CHD1 Protein

Overview

CHD1 (Chromodomain Helicase DNA Binding Protein 1) is an ATP-dependent chromatin remodeler essential for regulating gene expression, maintaining genomic integrity, and orchestrating epigenetic programs in eukaryotes. As a member of the SNF2H family of chromatin remodelers, CHD1 uses the energy from ATP hydrolysis to slide, restructure, and evict nucleosomes, thereby facilitating transcription factor access to DNA and maintaining proper chromatin architecture. With a molecular weight of ~223 kDa and containing 2,074 amino acids, CHD1 is particularly critical in neurons where precise epigenetic regulation underlies synaptic plasticity, learning, memory, and neuronal survival[@kelley2019].

CHD1 is distinguished by its two N-terminal chromodomains that specifically recognize methylated histone H3K4me3, targeting the protein to active promoter regions. The protein also contains SANT domains for histone tail binding and a central ATPase domain that performs nucleosome remodeling. CHD1 is essential for embryonic development, stem cell pluripotency, and neuronal function, making it a critical protein in both development and disease contexts.

<div class="infobox infobox-protein">

| Property | Value |
|----------|-------|
| Protein Name | Chromodomain Helicase DNA Binding Protein 1 |
| Gene | [CHD1](/genes/chd1) |
| UniProt ID | [Q86W28](https://www.uniprot.org/uniprot/Q86W28) |
| PDB ID | [5O9G](https://www.rcsb.org/structure/5O9G), [6BP5](https://www.rcsb.org/structure/6BP5) |
| Molecular Weight | ~223 kDa (2,074 aa) |
| Subcellular Localization | Nucleus |
| Protein Family | CHD (chromodomain helicase/ATPase) family |
| ATPase Activity | ~0.5 μmol/min/mg |

</div>

Structural Architecture

Domain Organization

CHD1 contains several distinct functional domains:

[ CHD1/2 ]-[ SANT1 ]-[ SANT2 ]-[ SLIDE ]-[ ATPase/DExx ]-[ Helicase C ]
1-400 400-500 500-600 600-700 700-1300 1300-2074

Functional Domains:

| Domain | Position | Function |
|--------|----------|----------|
| Chromodomain 1/2 | 1-400 | H3K4me3 recognition, targeting |
| SANT1/2 | 400-600 | Histone tail binding |
| SLIDE | 600-700 | DNA binding, substrate recognition |
| ATPase/DExx | 700-1300 | Nucleosome remodeling (ATP hydrolysis) |
| Helicase C | 1300-2074 | Regulatory domain |

Chromodomains

The two N-terminal chromodomains areSignature features of CHD1:

• Recognition specificity: Bind to H3K4me3 at active promoters
• Histone binding: Recognize methylated lysine residues on histone H3
• Targeting function: Direct CHD1 to transcriptionally active regions
• Cooperative binding: Two domains work together for optimal binding

ATPase Domain

The central ATPase domain provides the mechanical work for remodeling:

• SNF2H-like core: Belongs to the SNF2 family of ATPases
• DNA translocation: Uses ATP hydrolysis to move along DNA
• Nucleosome remodeling: Triggers conformational changes in nucleosomes
• Energy coupling: Converts ATP energy to mechanical work

SANT Domains

SANT (Swi3, Ada2, N-CoR, TFIIIB) domains:

• Histone contacts: Bind to histone tails
• Allosteric regulation: Modulate ATPase activity
• Substrate specificity: Determine nucleosome targeting
• Linker function: Connect chromatin recognition to remodeling

Biophysical Properties

Enzymatic Activity

CHD1 exhibits ATP-dependent chromatin remodeling:

| Property | Value | Notes |
|----------|-------|-------|
| ATPase activity | Basal: low; stimulated: high | Stimulated by nucleosomes |
| Nucleosome sliding | 20-50 bp/step | Directional repositioning |
| Remodeling speed | ~1 nucleosome/second | Processive activity |
| DNA binding affinity | Kd ~10 nM | Nucleosome substrate |
| Histone binding | H3 tail preference | H3K4me3 enhances |

Substrate Specificity

CHD1 shows preference for:

• Nucleosomal substrates: Requires nucleosomes, not free DNA
• H3K4me3: Methylation enhances recruitment
• Active promoters: Targeted to transcription start sites
• Nucleosome spacing: Influences dinucleosome positioning

Normal Physiological Functions

Chromatin Remodeling

CHD1 remodels chromatin through multiple mechanisms[@barozzi2014]:

Nucleosome Sliding:

• Repositions nucleosomes along DNA
• Creates nucleosome-free regions at promoters
• Facilitates transcription factor access
• Regulates enhancer activity

• Complete removal of nucleosomes in some contexts
• Enables major transcriptional changes
• Creates open chromatin regions

• Alters nucleosome composition
• Changes histone-DNA contacts
• Modulates chromatin accessibility

Transcriptional Regulation

CHD1 is centrally involved in transcription[@toma2008]:

Promoter Clearance:

• Facilitates RNAPII promoter clearance
• Removes nucleosomal barriers
• Transitions to productive elongation

• Associates with elongating RNAPII
• Couples transcription to nucleosome remodeling
• Prevents backtracking

• Influences co-transcriptional splicing
• Nucleosome positioning affects splice sites
• Chromatin structure regulates splice site choice

DNA Repair Functions

CHD1 plays critical roles in genomic maintenance[@hersch2014]:

Nucleotide Excision Repair (NER):

• Remodels chromatin at damage sites
• Makes DNA accessible to repair enzymes
• Facilitates lesion recognition

• Couples repair to transcription
• Priority repair of actively transcribed genes
• Critical in post-mitotic neurons

• Remodels chromatin for HR machinery
• Promotes RAD51 loading
• Facilitates strand invasion

Stem Cell pluripotency

CHD1 is essential for maintaining pluripotency[@gaspar2014]:

• Core pluripotency factors: Co-operates with OCT4, SOX2, NANOG
• Enhancer regulation: Controls pluripotency gene enhancers
• Lineage specification: Modulates differentiation genes
• Epigenetic memory: Maintains epigenetic states

Synaptic Plasticity

CHD1 in神经元 is critical for neuronal function[@simpson2016]:

Immediate-Early Gene Expression:

• Regulates c-Fos, Arc, Egr1 expression
• Controls activity-dependent transcriptional programs
• Enables synaptic strengthening

• Histone modifications in memory formation
• Required for long-term memory
• Activity-regulated chromatin remodeling

Role in Neurodegenerative Diseases

Amyotrophic Lateral Sclerosis (ALS)

CHD1 mutations are found in familial ALS[@sathyanarayana2017]:

Pathogenic Mechanisms:

• Disrupted chromatin remodeling in motor neurons
• Impaired DNA repair pathways
• Altered transcriptional regulation

• Rare missense mutations in ALS families
• Variable penetrance
• Often de novo mutations

• Enhancers of remaining CHD1 function
• Compensatory chromatin pathways
• Gene therapy approaches

Neurodevelopmental Disorders

CHD1 variants cause developmental disorders[@park2018]:

Intellectual Disability:

• De novo mutations identified
• Impaired cognitive function
• Variable severity

• CHD1 in ASD genetic cohorts
• Social and communication deficits
• Often with developmental delay

• Disrupted chromatin regulation
• Altered neuronal differentiation
• Impaired synaptic development

Alzheimer's Disease

Emerging evidence for CHD1 in AD:

Transcriptional Dysregulation:

• Altered CHD1 expression in AD brains
• Impaired epigenetic regulation
• Memory consolidation defects

• Epigenetic therapy targets
• Modulating chromatin state
• Enhancing DNA repair

Molecular Mechanisms

Histone Modification Crosstalk

CHD1 interacts with histone modifications:

| Modification | Interaction | Consequence |
|-------------|-------------|--------------|
| H3K4me3 | Direct binding | Targeting to active promoters |
| H3K27ac | Cooperative | Enhanced remodeling |
| H3K36me3 | Elongation coupling | Transcription fidelity |
| H3K9me3 | Repression | Heterochromatin exclusion |

Genome Organization

CHD1 affects 3D genome architecture[@levy2017]:

Loop Extrusion:

• Participates in loop formation
• Maintains topologically associating domains (TADs)
• Regulates enhancer-promoter contacts

• Maintains A/B compartments
• Affects chromatin mobility
• Regulates nuclear architecture

Protein Complexes

CHD1 functions in multi-protein complexes[@schnei2008]:

• SAGA Complex: Coactivator complex for transcription
• PAF1 Complex: Transcription elongation
• CPTC: Elongation complex
• histone acetyltransferases: p300, GCN5

Therapeutic Targeting

Targeting Strategies

CHD1 can be pharmacologically modulated:

Direct Targeting:

• ATPase inhibitors (research stage)
• Protein-protein interaction blockers
• Allosteric modulators

• BET inhibitors (bromodomain)
• HDAC inhibitors
• Histone methylation modulators

Drug Development Landscape

| Approach | Development Stage | Indication |
|----------|-------------------|-------------|
| ATPase inhibitors | Preclinical | Cancer, ALS |
| BET inhibitors | Clinical trials | Cancer, inflammation |
| HDAC inhibitors | FDA approved | Cancer, neurology |
| Gene therapy | Early research | Genetic correction |

Clinical Challenges

Specificity:

• Similarity to other CHD family members
• Ubiquitous expression
• Essential functions

• CNS penetration required
• Cell-type specificity
• Temporal control needed

Research Methods

Experimental Systems

In Vitro:

• Purified protein assays
• Nucleosome remodeling assays
• Reporter constructs

• Conditional knockout mice
• CRISPR models
• Viral delivery

Biomarkers

CHD1 as Biomarker:

• Neuronal activity marker
• Epigenetic dysfunction indicator
• DNA repair capacity

Interactions and Network

CHD1 interacts with:

| Component | Interaction Type | Functional Consequence |
|-----------|-----------------|---------------------|
| H3K4me3 | Direct binding | Targeting |
| RNAPII | Physical association | Transcription |
| p300/CBP | Co-activator complex | Histone acetylation |
| SAGA | Co-complex | Coactivation |
| PAF1 | Elongation complex | Transcription |
| RAD51 | DNA repair | Homologous recombination |

See Also

• [CHD1 Gene](/genes/chd1) — Gene page for CHD1
• [Chromatin Remodeling](/mechanisms/chromatin-remodeling)
• [Epigenetic Regulation](/mechanisms/epigenetic-regulation)
• [DNA Repair Mechanisms](/mechanisms/dna-repair)
• [Transcription Regulation](/mechanisms/transcription-regulation)
• [ALS](/diseases/amyotrophic-lateral-sclerosis)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Neurodevelopmental Disorders](/mechanisms/neurodevelopment)
• [Synaptic Plasticity](/mechanisms/synaptic-plasticity)

External Links

• [UniProt: Q86W28](https://www.uniprot.org/uniprot/Q86W28)
• [NCBI Gene: CHD1](https://www.ncbi.nlm.nih.gov/gene/1105)
• [RCSB PDB: 5O9G](https://www.rcsb.org/structure/5O9G)
• [RCSB PDB: 6BP5](https://www.rcsb.org/structure/6BP5)

References